Knowledge Mobilisation of England’s National Surveillance Report on Antimicrobial Utilisation and Resistance: Evaluation of Feedback from ESPAUR Report Users

Abstract The annual ESPAUR report contains national antimicrobial resistance (AMR), and antimicrobial consumption (AMC) surveillance data, as well as information on antimicrobial stewardship (AMS) efforts, awareness activities, the latest research that is ongoing in the field of AMR and actions being taken by ESPAUR Oversight Group members to tackle AMR. Survey Feedback: Ahead of the 2023-24 ESPAUR annual webinar, a survey was used to gather insights from report users, such as the most used chapters of the report and the ways the report was used in practice (Figure 1). The survey received 389 responses in total; pharmacist was the most commonly reported profession (33.7%, 131/389), followed by infection prevention and control specialist (13.6%, 53/389), and doctor (10.5%, 41/389). Feedback was mostly positive with 92.3% (359/389) of the respondents reporting that they would recommend the ESPAUR report to other stakeholders.Figure 1.ESPUAR report user feedback from webinar survey, 2024 and ways which the ESPAUR report has been used. Permission for use granted by UKHSA ESPAUR team. For those who answered questions relating to use of the report, the three most regularly used chapters were the AMR (67.9%, 165/243), AMS (53.9%, 131/243) and AMC (45.3%, 110/243) chapters. Furthermore, over a third of respondents reported that they accessed three or more chapters (39.9%, 97/243). The most reported reasons for accessing the report were for gathering information (18.8%, 58/308), for personal learning (10.1%, 31/308), or for sharing information with others (9.7%, 30/308). Many survey respondents (33.1%, 102/308) reported using the report for all the reasons listed within the survey. A series of infographics depicting the report’s key findings are published alongside the report. Most respondents reported that they found the infographics useful (83.9%, 219/261). ESPAUR Evaluation: A recent scoping review investigating the use of UKHSA AMS tools in secondary care included an evaluation of the ESPAUR report (Figure 1). The evaluation found that the report host website received 14,999 visits from September 2020 to October 2024. Results from PubMed literature and the Policy Commons grey literature database searches conducted between October and November 2024 showed the report was referenced in 63 articles. Wide use of the ESPAUR report by English hospitals was evident and the report also featured in National Institute for Health and Care Excellence guidance references and in national AMS papers, such as the Surveillance of Antimicrobial Use and Resistance in Northern Ireland Annual Report and the UK One Health Report. The report featured internationally as an example of reporting in papers from New Zealand, France, the European Centre for Disease Prevention and Control, and the Global Leading Health Systems Network. Furthermore, the 2024-25 ESPAUR report contains information on how robust national surveillance data can be used by frontline clinicians to inform clinical decisions to tackle AMR and to address health inequalities in AMR and antimicrobial use. Conclusions: This abstract highlights the importance of knowledge mobilising the ESPAUR report to the wider healthcare workforce and evaluating user feedback for continual improvement. Using the feedback gathered from frontline clinicians, future work will aim to understand how surveillance data is used and identify more effective methods of engaging and supporting this audience.